Post-translational modifications of EMT transcriptional factors in cancer metastasis

被引:12
|
作者
Chang, Rui [2 ]
Zhang, Peng [1 ]
You, Jiacong [2 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Cardiothorac Surg, Tianjin 300052, Peoples R China
[2] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin 300052, Peoples R China
来源
OPEN LIFE SCIENCES | 2016年 / 11卷 / 01期
关键词
EMT; acetylation; phosphorylation; transcriptional factor; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; BREAST-CANCER; HISTONE DEACETYLASE; GSK-3-BETA-MEDIATED PHOSPHORYLATION; LUNG-CANCER; DNA-DAMAGE; SNAIL; PROMOTES; CELLS;
D O I
10.1515/biol-2016-0033
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Metastasis is an important reason for death of cancer patients which characterized as the formation of secondary cancers at distant sites. Epithelial-mesenchymal transition (EMT) is a dynamic process that appear to facilitate tumor metastasis in various cancers by switching epithelial cells into mesenchymal properties. Although previous investigation suggested a key role of EMT transcriptional factors in suppression of E-cadherin, the association of these factors with other cellular regulators in cancer metastasis need to be fully elucidated. Post-translational modifications (PTMs), such as acetylation and phosphorylation, have emerged as an important mechanism to modulate biological behavior of substrate proteins. In this review, we summarized protein modification and subsequent function changes of Snail, Twist and ZEB, as well as their influence on tumor progression. Acetylation of EMT transcriptional factors usually cause nuclear localization and/or protein stabilization thus contribute to E-cadherin repression. Besides, Twist and ZEB were phosphorylated by diverse kinases to promote metastasis in many cancers, while Snail was negatively regulated by phosphorylation to degradation. Then, the potential of therapy for metastasis by targeting PTMs-involved regulation of EMT transcriptional factors were discussed.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [21] Post-Translational Modifications and Diabetes
    Sharma, Chiranjeev
    Hamza, Abu
    Boyle, Emily
    Donu, Dickson
    Cen, Yana
    BIOMOLECULES, 2024, 14 (03)
  • [22] Post-translational modifications - Editorial
    Packer, NH
    PROTEOMICS, 2001, 1 (02) : U5 - U6
  • [23] Targeting Post-Translational Modifications
    DePalma, Angelo
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2009, 29 (03): : 40 - 41
  • [24] Post-translational modifications of transporters
    Czuba, Lindsay C.
    Hillgren, Kathleen M.
    Swaan, Peter W.
    PHARMACOLOGY & THERAPEUTICS, 2018, 192 : 88 - 99
  • [25] Pathological implication of protein post-translational modifications in cancer
    Pan, Sheng
    Chen, Ru
    MOLECULAR ASPECTS OF MEDICINE, 2022, 86
  • [26] Protein post-translational modifications in the regulation of cancer hallmarks
    Wang, Haiying
    Yang, Liqian
    Liu, Minghui
    Luo, Jianyuan
    CANCER GENE THERAPY, 2023, 30 (04) : 529 - 547
  • [27] Post-translational modifications of EZH2 in cancer
    Zhongwei Li
    Minle Li
    Diandian Wang
    Pingfu Hou
    Xintian Chen
    Sufang Chu
    Dafei Chai
    Junnian Zheng
    Jin Bai
    Cell & Bioscience, 10
  • [28] The role of protein post-translational modifications in prostate cancer
    Hao, Yinghui
    Gu, Chenqiong
    Luo, Wenfeng
    Shen, Jian
    Xie, Fangmei
    Zhao, Ying
    Song, Xiaoyu
    Han, Zeping
    He, Jinhua
    PEERJ, 2024, 12
  • [29] Protein post-translational modifications in the regulation of cancer hallmarks
    Haiying Wang
    Liqian Yang
    Minghui Liu
    Jianyuan Luo
    Cancer Gene Therapy, 2023, 30 : 529 - 547
  • [30] Advances in post-translational modifications of proteins and cancer immunotherapy
    Li, Yanqing
    Zhang, Runfang
    Hei, Hu
    FRONTIERS IN IMMUNOLOGY, 2023, 14